Voyager Therapeutics, Inc. (VYGR): Price and Financial Metrics

Voyager Therapeutics, Inc. (VYGR)

Today's Latest Price: $10.63 USD

0.33 (-3.01%)

Updated Oct 30 4:00pm

Add VYGR to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 240 in Medical - Pharmaceuticals

See all "A" rated Strong Buy stocks

VYGR Stock Summary

  • Of note is the ratio of Voyager Therapeutics Inc's sales and general administrative expense to its total operating expenses; just 11.21% of US stocks have a lower such ratio.
  • For VYGR, its debt to operating expenses ratio is greater than that reported by only 0.36% of US equities we're observing.
  • As for revenue growth, note that VYGR's revenue has grown 80.29% over the past 12 months; that beats the revenue growth of 93.41% of US companies in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Voyager Therapeutics Inc are CTMX, PIRS, NTLA, CRBP, and KALV.
  • Visit VYGR's SEC page to see the company's official filings. To visit the company's web site, go to

VYGR Stock Price Chart Interactive Chart >

Price chart for VYGR

VYGR Price/Volume Stats

Current price $10.63 52-week high $16.53
Prev. close $10.96 52-week low $6.26
Day low $10.27 Volume 131,500
Day high $10.98 Avg. volume 310,208
50-day MA $11.31 Dividend yield N/A
200-day MA $11.47 Market Cap 397.89M

Voyager Therapeutics, Inc. (VYGR) Company Bio

Voyager Therapeutics, Inc., a clinical-stage gene therapy company, focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. The company was founded in 2013 and is based in Cambridge, Massachusetts.

VYGR Latest News Stream

Event/Time News Detail
Loading, please wait...

VYGR Latest Social Stream

Loading social stream, please wait...

View Full VYGR Social Stream

Latest VYGR News From Around the Web

Below are the latest news stories about Voyager Therapeutics Inc that investors may wish to consider to help them evaluate VYGR as an investment opportunity.

Neurocrine Biosciences and Voyager Therapeutics Present New Long-Term Three-Year Data Demonstrating that One-Time Treatment with an Investigational Gene Therapy Showed Sustained Improvement in Motor Function in Patients with Parkinson's Disease

SAN DIEGO and CAMBRIDGE, Mass., Sept. 11, 2020 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Voyager Therapeutics, Inc. (Nasdaq: VYGR) today announced data from PD-1101, a Phase Ib open-label, three-year efficacy and safety study, demonstrating that a one-time treatment…

PR Newswire | September 11, 2020

Voyager Therapeutics to Report Second Quarter 2020 Financial Results and Participate in Upcoming Investor Conferences

CAMBRIDGE, Mass., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on…

GlobeNewswire | August 3, 2020

Homology Medicines (FIXX) Looks Good: Stock Adds 8% in Session

Homology Medicines (FIXX) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

Yahoo | July 8, 2020

Hedge Funds Are Selling Voyager Therapeutics, Inc. (VYGR)

The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings to a certain extent level the playing field for ordinary investors. The latest round of 13F […]

Yahoo | June 27, 2020

Neurocrine Adds to Pipeline With $2 Billion Takeda Deal

Biotech gets 7 drugs in partnership, 3 of which are in phase 2 testing Continue reading...

Yahoo | June 17, 2020

Read More 'VYGR' Stories Here

VYGR Price Returns

1-mo -1.57%
3-mo -3.97%
6-mo -4.49%
1-year -34.18%
3-year -48.07%
5-year N/A
YTD -23.80%
2019 48.40%
2018 -43.37%
2017 30.30%
2016 -41.83%
2015 N/A

Continue Researching VYGR

Here are a few links from around the web to help you further your research on Voyager Therapeutics Inc's stock as an investment opportunity:

Voyager Therapeutics Inc (VYGR) Stock Price | Nasdaq
Voyager Therapeutics Inc (VYGR) Stock Quote, History and News - Yahoo Finance
Voyager Therapeutics Inc (VYGR) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7179 seconds.